| Not Yet Recruiting | Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) NCT07411599 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Not Yet Recruiting | The PharmFIT Study NCT06656936 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Not Yet Recruiting | Colorectal Cancer Screening in the Homeless NCT07220018 | George Washington University | N/A |
| Not Yet Recruiting | Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Red NCT07429487 | Centre Antoine Lacassagne | N/A |
| Not Yet Recruiting | A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer NCT07225309 | Memorial Sloan Kettering Cancer Center | N/A |
| Not Yet Recruiting | Effect of Video Training on Patients' Self-Efficacy After Colorectal Surgery NCT07078656 | Ankara Yildirim Beyazıt University | N/A |
| Not Yet Recruiting | Guardant Shield Colorectal Cancer Screening NCT07436637 | University of Miami | N/A |
| Not Yet Recruiting | A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Sta NCT07525206 | AbbVie | Phase 3 |
| Not Yet Recruiting | Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal Cancer Using a Blood NCT07340567 | UNICANCER | Phase 3 |
| Not Yet Recruiting | An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients Fro NCT07527832 | Pfizer | — |
| Not Yet Recruiting | Evaluation of Skin Tests in Biotherapy Allergies NCT06971848 | University Hospital, Angers | N/A |
| Not Yet Recruiting | Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in NCT07500259 | Luxembourg Institute of Health | — |
| Not Yet Recruiting | CARE Tool Study Aim 3 NCT07296887 | Washington University School of Medicine | N/A |
| Not Yet Recruiting | SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study NCT07515820 | Meng Qiu | Phase 2 |
| Not Yet Recruiting | Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies NCT07504263 | Recurv Pharma Inc | Phase 1 / Phase 2 |
| Enrolling By Invitation | Natural History Study of Early Life Exposures in Agriculture (ELEA) NCT07328516 | National Cancer Institute (NCI) | — |
| Not Yet Recruiting | Metabolomic Pathways and Traditional Chinese Medicine Body Constitution in Cancer-related Fatigue NCT07489833 | Chang Gung Memorial Hospital | — |
| Not Yet Recruiting | Anti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High NCT07094893 | Gruppo Oncologico del Nord-Ovest | Phase 4 |
| Not Yet Recruiting | Efficacy of AI-Assisted Colonoscopy for Screening Colorectal Neoplasia (AI-COLOSCREEN) NCT07307547 | Zhejiang University | N/A |
| Not Yet Recruiting | Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients NCT07403981 | Stanford University | N/A |
| Not Yet Recruiting | Effectiveness of a Multimodal Outpatient Supervised Physical Activity Program to Improve Tolerance and Efficac NCT07502963 | University of Vic - Central University of Catalonia | N/A |
| Recruiting | Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses NCT07276529 | GI Windows, Inc. | N/A |
| Not Yet Recruiting | A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer NCT07474727 | Multitude Therapeutics Inc. | Phase 2 |
| Not Yet Recruiting | Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced NCT07281768 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Recruiting | Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Ad NCT07152821 | Canadian Cancer Trials Group | Phase 3 |
| Recruiting | KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer NCT07353645 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Phase 1 / Phase 2 |
| Not Yet Recruiting | Optimising Colorectal Cancer Patient Pathways NCT07430540 | University of Edinburgh | N/A |
| Recruiting | [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications NCT07432633 | Blue Earth Diagnostics | Phase 1 / Phase 2 |
| Not Yet Recruiting | Construction and Evaluation of a Flipped Discharge Model for Stomates With Colorectal Cancer NCT07463690 | Sun Yat-sen University | N/A |
| Recruiting | Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar NCT07337590 | Exero Medical Ltd. | N/A |
| Recruiting | Functional and Respiratory Determinants of Long-Term Colorectal Cancer Outcomes NCT07523919 | Inonu University | — |
| Recruiting | A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsa NCT07506109 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Not Yet Recruiting | YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line Treatment NCT07409805 | West China Hospital | Phase 1 |
| Not Yet Recruiting | A Prospective Study Assessing ActivSight Imaging for Intraoperative Perfusion Evaluation in Left-Sided Colecto NCT07453797 | Activ Surgical | N/A |
| Not Yet Recruiting | Everolimus in CDK12-Deficient Metastatic Colorectal Cancer (EVER-RECODE) NCT07435584 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 1 / Phase 2 |
| Not Yet Recruiting | Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway NCT07237984 | Nordsjaellands Hospital | — |
| Recruiting | GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CR NCT06558773 | Chinese PLA General Hospital | Phase 2 |
| Not Yet Recruiting | Clinical Trial of TB511 in Advanced Solid Tumors NCT06400160 | Twinpig Biolab, Inc. | Phase 1 / Phase 2 |
| Not Yet Recruiting | Optimizing Patient Treatment With EPA-enriched Nutrition, a Randomised Control Trial NCT07255066 | University of Edinburgh | N/A |
| Suspended | Protocol to Validate the Performance of the LifeKit® Prevent Colorectal Neoplasia Test for CRC Screening NCT04693546 | Metabiomics Corp | — |
| Not Yet Recruiting | Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patie NCT07219238 | GE Healthcare | Phase 2 / Phase 3 |
| Not Yet Recruiting | PIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases NCT07411781 | Chinese PLA General Hospital | Phase 1 |
| Not Yet Recruiting | SAMe in Prevention of Oxaliplatin-associated Liver Injury NCT06258525 | Cedars-Sinai Medical Center | Phase 2 |
| Not Yet Recruiting | Integrating Peritoneal Histological Growth Patterns Into Preoperative Decision-Making for Colorectal Peritonea NCT07474025 | Jules Bordet Institute | — |
| Recruiting | Functional and Respiratory Predictors of Early Postoperative Outcomes NCT07529301 | Müşerref Ebru YALÇIN | — |
| Not Yet Recruiting | Liver-directed Chemotherapy After Surgery of Liver Metastases of Colorectal Cancer in Patients With High Risk NCT07284394 | UNICANCER | Phase 3 |
| Recruiting | Anlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver Metastatic Colorectal Cancer NCT07398326 | Shanghai Changzheng Hospital | Phase 2 |
| Recruiting | A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types NCT07503808 | IDEAYA Biosciences | Phase 1 |
| Recruiting | 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors NCT07189871 | Radiopharm Theranostics, Ltd | Phase 1 / Phase 2 |
| Recruiting | Peripheral Autonomic Block (BAP) Plus Transversus Abdominis Plane Block (TAP) for Postoperative Analgesia Afte NCT07388953 | Faculdade de Ciências Médicas de Minas Gerais | N/A |
| Suspended | Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Can NCT07071961 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | A Single Center Evaluation of AI Enabled SureForm Robotic Stapler (SureformTM) Compared to Conventional Staple NCT07371832 | Asian Institute of Gastroenterology, India | — |
| Recruiting | EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676 | Essen Biotech | Phase 1 / Phase 2 |
| Not Yet Recruiting | SL-28 for Advanced Solid Tumours NCT07341737 | Second Life Therapeutics | Phase 1 / Phase 2 |
| Not Yet Recruiting | Clinical Trial Protocol for Evaluating the Efficacy and Safety of Thoracoabdominal Endoscopic Surgery System i NCT07382635 | Cornerstone Robotics | — |
| Not Yet Recruiting | A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizum NCT07229846 | Yanqiao Zhang | Phase 2 |
| Not Yet Recruiting | GUCY2C Prime-Boost Vaccination for Advanced Colorectal and Small Bowel Adenocarcinomas NCT07417488 | Thomas Jefferson University | Phase 1 |
| Active Not Recruiting | Local Treatment Strategies for Brain Metastases of Colorectal Cancer NCT07448662 | Blokhin's Russian Cancer Research Center | — |
| Recruiting | Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial NCT07227077 | Medical College of Wisconsin | N/A |
| Withdrawn | A Study to Evaluate the Efficacy and Safety of Inavolisib When Administered in Combination With Bevacizumab an NCT07323576 | Hoffmann-La Roche | Phase 2 |
| Not Yet Recruiting | The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal NCT05776381 | Vejle Hospital | Phase 2 |
| Not Yet Recruiting | Quantitative Fecal Immunochemical Test for Detection of Colorectal Cancer and Precancerous Lesions in Sohag NCT07410546 | Sohag University | — |
| Not Yet Recruiting | Fruquintinib Versus Bevacizumab Plus Chemotherapy in Second-Line RAS-Mutant Metastatic Colorectal Cancer (FRU- NCT07362836 | Fudan University | Phase 3 |
| Not Yet Recruiting | A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tu NCT07272642 | Radiopharm Theranostics, Ltd | Phase 1 |
| Not Yet Recruiting | Chemo Brain Prehab Project NCT07341217 | Dr. Chris Gaffney | N/A |
| Not Yet Recruiting | Phase Ib/II Study of QL1706 + Fruquintinib + SCRT vs. Standard Third-Line Therapy in Unresectable Liver-Metast NCT07353268 | Tao Zhang | Phase 2 |
| Recruiting | First in Human Study of SIM0610 in Solid Tumors NCT07348211 | Jiangsu Simcere Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for NCT07235293 | Kahr Bio Australia Pty Ltd | Phase 2 |
| Recruiting | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell NCT07321106 | Cartography Biosciences | Phase 1 |
| Enrolling By Invitation | SafeHeal Colovac Anastomosis Protection Device Evaluation Pivotal Study NCT07116668 | SafeHeal Inc | N/A |
| Recruiting | Comparative Study on the Short- and Long-term Efficacy of Q-ISR, Traditional Sub-ISR, and t-ISR NCT07371273 | Fudan University | Phase 2 |
| Recruiting | Single-Stapled Technique for Colorectal Anastomosis NCT07417358 | Umeå University | — |
| Not Yet Recruiting | Prophylactic PIPAC in Patients With High-risk Colorectal Cancer NCT06839092 | Jeremy Meyer | Phase 3 |
| Recruiting | The Effect of Mandala Art Therapy, Psychological Resilience, Coping With Cancer, Colorectal Cancer Surgery NCT07535021 | Cumhuriyet University | N/A |
| Not Yet Recruiting | First in Human Study of QLS5316 in Solid Tumors NCT07358884 | Qilu Pharmaceutical Co., Ltd. | Phase 1 |
| Not Yet Recruiting | Impact of a Proactive Strategy of General Practitioners on CRC Screening NCT06664567 | University Hospital, Bordeaux | — |
| Not Yet Recruiting | Neoadjuvant Chemotherapy, Anti-PD-1 Antibody and Sitagliptin for Locally Advanced pMMR CRC NCT07365592 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 1 / Phase 2 |
| Recruiting | Large Language Models Assist in Tumor MDT NCT07504367 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | N/A |
| Not Yet Recruiting | Fruquintinib Combined With Trifluridine/Tipiracil Versus Bevacizumab Combined With Trifluridine/Tipiracil for NCT07286695 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Not Yet Recruiting | Clinical Performance of the Mainz Biomed Colorectal Cancer Screening Test for Colorectal Cancer and Advanced A NCT05636085 | Mainz Biomed | — |
| Not Yet Recruiting | XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation NCT05275374 | Xynomic Pharmaceuticals, Inc. | Phase 1 / Phase 2 |
| Recruiting | Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial NCT07447050 | University of California, Irvine | Phase 2 |
| Enrolling By Invitation | Confirming the Accuracy of Endoscopic Marking Using a New Marker, a Novel Luminomarker, in Lesion Marking Befo NCT07380867 | Seoul St. Mary's Hospital | N/A |
| Recruiting | The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and NCT06717295 | Javier Toledo | — |
| Recruiting | Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities NCT06722183 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Phase 2 |
| Recruiting | A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumor NCT07318805 | Pfizer | Phase 1 |
| Recruiting | The Florida ASCENT Study NCT07042243 | University of Florida | N/A |
| Not Yet Recruiting | A Single-arm Clinical Study Evaluating Pirfenidone and Sintilimab in Combination With Standard Neoadjuvant Che NCT07268677 | Guoxiang Cai | Phase 2 |
| Not Yet Recruiting | A Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Fruquintinib in the Treatment of Imm NCT07229872 | Harbin Medical University | Phase 2 |
| Not Yet Recruiting | Reducing Neoplasia Recurrence After Non-thermal Endoscopic Resection of Large Colorectal Polyps NCT07242820 | Centre hospitalier de l'Université de Montréal (CHUM) | N/A |
| Recruiting | FL-261 Imaging for Cancer Diagnosis and Staging NCT07510321 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | — |
| Recruiting | Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors NCT07261631 | Novartis Pharmaceuticals | Phase 1 |
| Not Yet Recruiting | A Study of Tumor-Agnostic MRD Detection in Stage III Colorectal Cancer NCT07254156 | Sun Yat-sen University | — |
| Recruiting | A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors NCT07300150 | PAQ Therapeutics, Inc. | Phase 1 |
| Recruiting | Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Thi NCT07343791 | JIANG LONGWEI | EARLY_Phase 1 |
| Recruiting | A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With m NCT06948448 | Ono Pharmaceutical Co., Ltd. | Phase 2 |
| Recruiting | Holistic Acupuncture for Patients With Chemotherapy Induced Nausea NCT07201194 | Vejle Hospital | N/A |
| Recruiting | AI-Assisted Chemotherapy Side Effect Management NCT07198581 | Incheon St.Mary's Hospital | N/A |
| Recruiting | A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer NCT07227168 | Sutro Biopharma, Inc. | Phase 1 |
| Recruiting | A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy NCT07227636 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Recruiting | FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors NCT07216105 | Fate Therapeutics | Phase 1 |
| Not Yet Recruiting | Transanal Irrigation for the Management of Early Low Anterior Resection Syndrome (LARS) NCT07219745 | Case Comprehensive Cancer Center | N/A |
| Recruiting | Effect of OFA, OSA Versus Opioid-based Anesthesia on NETs and Cancer Cell Malignancy After Colorectal Cancer S NCT07264556 | Fudan University | N/A |
| Not Yet Recruiting | Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer NCT07166263 | Base Therapeutics (Shanghai) Co., Ltd. | EARLY_Phase 1 |
| Not Yet Recruiting | The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer NCT07152886 | The Affiliated Hospital of Qingdao University | Phase 4 |
| Recruiting | A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory NCT06992258 | Criterium, Inc. | Phase 2 |
| Recruiting | Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic C NCT07407465 | Gruppo Oncologico del Nord-Ovest | Phase 2 |
| Recruiting | PRIORITY-CONNECT 2 Trial NCT06976710 | Surgical Outcomes Research Centre (SOuRCe) | N/A |
| Not Yet Recruiting | ONLOOP Trial: Evaluating a New Surveillance and Support System for Survivors of Childhood Cancer in Ontario NCT05832138 | The Hospital for Sick Children | N/A |
| Not Yet Recruiting | Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors NCT07172503 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | N/A |
| Recruiting | A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Canc NCT07011576 | SCRI Development Innovations, LLC | Phase 2 |
| Recruiting | A Study to Monitor the Fruzaqla Treatment of Adults With Metastatic Colorectal Cancer (mCRC) in South Korea NCT07035886 | Takeda | — |
| Enrolling By Invitation | AI-informed Colorectal Cancer (CRC) Screening Navigation vs. Standard of Care Among Screening-naive Penn Medic NCT07230795 | Abramson Cancer Center at Penn Medicine | N/A |
| Active Not Recruiting | Dose-dense Capecitabine Schedule [7days on _7 Days Off] in Colorectal Cancer in Comparison With Standered Regi NCT07215936 | Sohag University | Phase 2 |
| Recruiting | Pre-emptive Endoscopic Vacuum Therapy Reduces the Incidence of Anastomotic Leakage After Colorectal Cancer Sur NCT07208786 | Nanchong Central Hospital | N/A |
| Recruiting | A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cance NCT07136077 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | MIMICC Study in Patients With Colorectal Cancer NCT07494201 | Fondazione del Piemonte per l'Oncologia | N/A |
| Enrolling By Invitation | Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome NCT07106359 | University of Alabama at Birmingham | N/A |
| Withdrawn | A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With NCT06690281 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons Wit NCT07153016 | Masonic Cancer Center, University of Minnesota | N/A |
| Withdrawn | A Phase II Study Evaluating an Organ Preservation Strategy Using Immune Checkpoint Blockade for Participants W NCT06410534 | National Cancer Institute (NCI) | Phase 2 |
| Withdrawn | A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-l NCT07137390 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Not Yet Recruiting | A Study on the Efficacy and Safety of Irinotecan Liposome (II), 5-FU/LV in Combination With Bevacizumab for th NCT07123441 | Sanjun Cai | Phase 2 |
| Recruiting | Effect of Perioperative Lidocaine or High-Dose Dexamethasone on Immune Response in Colon Cancer Surgery (PILDI NCT07432399 | Institute of Oncology Ljubljana | Phase 2 |
| Not Yet Recruiting | Construction and Empirical Research of the Applicable Baduanjin Protocol for Patients With Colorectal Cancer E NCT07172087 | Sichuan Cancer Hospital and Research Institute | N/A |
| Recruiting | A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ So NCT07169734 | Alentis Therapeutics AG | Phase 1 / Phase 2 |
| Recruiting | Anastomotic Leakage After Colorectal Surgery. NCT07144683 | Minia University | — |
| Recruiting | IDOV-Immune for Advanced Solid Tumors NCT06910657 | ViroMissile, Inc. | Phase 1 |
| Withdrawn | Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Me NCT06603818 | National Cancer Institute (NCI) | Phase 2 |
| Not Yet Recruiting | AK112 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI as Second-line Treatment of MSS/pMMR Metastatic Colorectal NCT07021950 | Sun Yat-sen University | Phase 2 |
| Recruiting | China Colorectal Cancer Screening Trial 1 (C-Cost1) NCT07090291 | Zhejiang University | N/A |
| Completed | DevelopmentA Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer NCT07512726 | Ilknur Yazicioglu | N/A |
| Recruiting | A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously NCT07023289 | AbbVie | Phase 2 |
| Recruiting | A Study of YL202 in Patients With Advanced Solid Tumors NCT07202364 | MediLink Therapeutics (Suzhou) Co., Ltd. | Phase 2 |
| Recruiting | Phase II RCT of LCRT vs SCRT + CAPOX/PD-1i/COX-2i in MSS Locally Advanced Rectal Cancer NCT07154316 | Fudan University | Phase 2 |
| Enrolling By Invitation | Mechanical Bowel Preparation With or Without Oral Antibiotics in Left Sided Colorectal Cancer Surgery NCT07429760 | Shaukat Khanum Memorial Cancer Hospital & Research Centre | N/A |
| Recruiting | Effect of Thread Embedding Acupuncture on Postoperative Ileus Recovery After Colorectal Cancer Surgery: A Mult NCT07071987 | Northern Jiangsu People's Hospital | N/A |
| Recruiting | 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer NCT06298916 | Lantheus Medical Imaging | Phase 1 / Phase 2 |
| Recruiting | Safety and Efficacy of Canagliflozin in Patients With Metastatic High Microsatellite Instability (MSI-H) Color NCT07076823 | West China Hospital | Phase 1 |
| Recruiting | The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities NCT07086833 | Purdue University | N/A |
| Recruiting | A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors NCT07066657 | ArriVent BioPharma, Inc. | Phase 1 |
| Recruiting | A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors NCT07094204 | Astellas Pharma Inc | Phase 1 |
| Recruiting | A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer NCT07071714 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Phase 2 |
| Recruiting | Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors NCT06974110 | MOMA Therapeutics | Phase 1 |
| Recruiting | Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Can NCT06371768 | Duke University | N/A |
| Recruiting | Patient-reported Outcomes (PRO) and Treatment Outcomes of Chinese Patients With MSS-type Advanced Colorectal C NCT07105631 | West China Hospital | — |
| Recruiting | FITting Non-invasive Tests in Lynch Syndrome Surveillance NCT06898996 | University of Chicago | — |
| Not Yet Recruiting | China Colorectal Cancer Screening Trial 2 (C-Cost2) NCT07090304 | Zhejiang University | N/A |
| Not Yet Recruiting | ScreenTalk to Improve Colorectal Cancer Screening Uptake Among First-degree Relatives of Patients: a Study Pro NCT06710860 | Sun Yat-sen University | N/A |
| Not Yet Recruiting | Evaluating AI and Human Expert Decisions in Colorectal Cancer NCT07045207 | Peking University Cancer Hospital & Institute | — |
| Recruiting | Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis NCT07044362 | Case Comprehensive Cancer Center | N/A |
| Recruiting | PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival NCT06896162 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Recruiting | Adjuvant FOLFIRI Based-chemotherapy After Resection of CLM Responding to Preoperative FOLFIRI NCT06501482 | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Recruiting | An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorecta NCT07033026 | NGM Biopharmaceuticals, Inc | Phase 2 |
| Recruiting | A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors NCT07020221 | Verastem, Inc. | Phase 1 / Phase 2 |
| Not Yet Recruiting | A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors NCT07036185 | Shanghai Bao Pharmaceuticals Co., Ltd. | Phase 1 |
| Active Not Recruiting | mPATH-Cloud for Colorectal Cancer Screening NCT06441487 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Recruiting | KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal C NCT06411691 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 |
| Recruiting | A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer NCT06692959 | University of Southampton | Phase 2 |
| Recruiting | Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Colorecta NCT07068529 | Shanghai Minimally Invasive Surgery Center | — |
| Completed | ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors NCT06973161 | AstraZeneca | — |
| Completed | Colorectal Cancer Screening in Chinese Rural Communities NCT07180303 | The First Affiliated Hospital with Nanjing Medical University | N/A |
| Not Yet Recruiting | Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Pa NCT06414122 | University of Cologne | N/A |
| Not Yet Recruiting | The Application Value of Spectral CT in the Accurate Staging of Colorectal Cancer NCT06977373 | Yunnan Cancer Hospital | N/A |
| Withdrawn | TCR1020-CD8 T Cells in KRAS-mutated Cancers NCT06707896 | University of Pennsylvania | Phase 1 |
| Not Yet Recruiting | A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors NCT06963502 | Jiangsu Hansoh Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | Colorectal Cancers :A Retrospective Study NCT07024225 | Sohag University | — |
| Enrolling By Invitation | XS-03 in Combination With FOLFOX or FOLFIRI and Bevacizumab for Treatment of Metastatic Colorectal Cancer Pati NCT06936527 | NovaOnco Therapeutics Co., Ltd. | Phase 1 / Phase 2 |
| Recruiting | A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With S NCT06682793 | A2 Biotherapeutics Inc. | Phase 1 / Phase 2 |
| Not Yet Recruiting | A Real-World Study of Neoadjuvant/Conversion Therapy for Colorectal Cancer With Chemotherapy And Anti-Angiogen NCT06470178 | Wuhan University | — |
| Not Yet Recruiting | Postoperative Electrical Muscle Stimulation Two NCT06964438 | University of Nottingham | N/A |
| Not Yet Recruiting | Early Diagnosis and Recurrence Monitoring of Colorectal Cancer NCT06991452 | Huashan Hospital | — |
| Recruiting | Lead-212 PSV359 Therapy for Patients With Solid Tumors NCT06710756 | Perspective Therapeutics | Phase 1 / Phase 2 |
| Recruiting | Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Pa NCT06878131 | M.D. Anderson Cancer Center | — |
| Recruiting | OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction NCT06462963 | European Organisation for Research and Treatment of Cancer - EORTC | N/A |
| Recruiting | Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies NCT07327489 | Elephas | — |
| Recruiting | SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases NCT06794086 | Jun Huang | Phase 3 |
| Not Yet Recruiting | To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant NCT06948539 | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid NCT06910670 | Washington University School of Medicine | N/A |
| Recruiting | Impact of Aerobic Exercise on the Anticancer Immune Response in Patients Receiving Cancer Treatment NCT06911970 | Université de Sherbrooke | N/A |
| Recruiting | CT-95 in Advanced Cancers Associated With Mesothelin Expression NCT06756035 | Context Therapeutics Inc. | Phase 1 |
| Recruiting | Adaptive Anastomosis for Anterior Resection in Sigmoid and Proximal Rectal Cancer or Premalignant Lesions NCT07056374 | Amsterdam UMC, location VUmc | — |
| Recruiting | Role of Photon Counting CT in Detecting Liver Metastatis From Colorectal Cancer NCT06753903 | IRCCS San Raffaele | — |
| Active Not Recruiting | JAB-21822 Combined With Chemotherapy and Bevacizumab in Second-line KRAS G12C CRC NCT06838338 | Jian Li | Phase 1 |
| Active Not Recruiting | Plasma Multi - Omics Detection for Evaluating Efficacy and Recurrence Risk in Oligometastatic Colorectal Cance NCT07492238 | Xiujuan Qu | N/A |
| Recruiting | Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment o NCT06356714 | Sun Jing | Phase 2 |
| Recruiting | Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors NCT06940102 | Changchun GeneScience Pharmaceutical Co., Ltd. | — |
| Recruiting | Circulating Tumor DNA in Patients Summoned for Colonoscopy; - a Liquid Biopsy for Detection, Characterization, NCT06307938 | Helse Nord-Trøndelag HF | — |
| Recruiting | Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer NCT06728072 | Virginia Commonwealth University | Phase 2 |
| Completed | Frailty Score and Postoperative Morbidity in Colorectal Cancer Surgery NCT06866678 | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital | — |
| Not Yet Recruiting | Serum MicroRNAs as Diagnostic Biomarkers of Colorectal Cancer NCT06738225 | Bishoy Shehata | — |
| Not Yet Recruiting | Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Ty NCT06858956 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | — |
| Not Yet Recruiting | Intrathecal Morphine Versus Epidural Analgesia for Laparoscopic Colon Surgery NCT06881563 | Meri Mirceta | Phase 4 |
| Not Yet Recruiting | Effect of Arm Cycling Exercise on Pulmonary Functions After Colectomy In Elderly NCT06876961 | Cairo University | N/A |
| Not Yet Recruiting | Lipid Mediators & Cancer: Montelukast, SPM, and Almonds NCT06887673 | University of South Florida | EARLY_Phase 1 |
| Not Yet Recruiting | ProSight: a Multi-centre Interventional Study Evaluating MCED in Asymptomatic Population NCT06790355 | Shanghai Weihe Medical Laboratory Co., Ltd. | N/A |
| Recruiting | LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis NCT06848465 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Phase 1 |
| Recruiting | Low Versus Standard Intraabdominal Pressure in Robot-assisted Colorectal Cancer Surgery NCT06783244 | Victoria Rosberg | N/A |
| Not Yet Recruiting | Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program (LIFE-SCREEN) NCT06827366 | Centre Leon Berard | N/A |
| Recruiting | Microbiome-based Diagnostic Tool for the Screening of Colorectal Cancer (GUILTI) NCT06738173 | Catholic University of the Sacred Heart | — |
| Recruiting | Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery NCT06731998 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | N/A |
| Terminated | YASU Research Registry: For Young Adults With Cancer NCT06275854 | Young Adult Survivors United | — |
| Recruiting | Multi-scale Spatio-Temporal Analysis of Research Data NCT07189312 | Universidad de Granada | — |
| Recruiting | Study to Evaluate the Use of Capecitabine in Monotherapy and in Combination With Oxaliplatin in Elderly Patien NCT06888843 | Nizhny Novgorod Regional Clinical Oncology Center | Phase 2 |
| Not Yet Recruiting | A Prospective, Open-label, Single-arm Phase II Clinical Study of Fruquintinib Combined With S-1 for the Treatm NCT06746545 | Fujian Cancer Hospital | Phase 2 |
| Recruiting | Complete Closure After Endoscopic Mucosal Resection of Large Non-Pedunculated Colorectal Polyps NCT06807073 | Centre hospitalier de l'Université de Montréal (CHUM) | N/A |
| Not Yet Recruiting | Evaluation of Gixam's Efficacy Predicting Pre-cancerous Colorectal Polyps and Colorectal Cancer NCT06688110 | Jubaan Ltd. | N/A |
| Recruiting | Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions NCT07066046 | Instituto do Cancer do Estado de São Paulo | N/A |
| Withdrawn | UNTIRE: Cancer-related Fatigue With Digital Treatment NCT05584540 | Dana-Farber Cancer Institute | N/A |
| Completed | Effect of Preoperative ERAS Education on Recovery After Colorectal Surgery NCT07324369 | Izmir Katip Celebi University | N/A |
| Active Not Recruiting | Use of Alternative and Complementary Medicine by Colorectal Cancer Patients NCT06779669 | University Hospital, Limoges | N/A |
| Recruiting | Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzy NCT06475352 | UNICANCER | Phase 2 |
| Recruiting | Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA NCT07224789 | City of Hope Medical Center | — |
| Recruiting | A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously NCT06562543 | Takeda | Phase 4 |
| Recruiting | A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors NCT06695845 | Jazz Pharmaceuticals | Phase 2 |
| Completed | Social Media and Cancer Screening Information NCT06712901 | University of Utah | N/A |
| Recruiting | Telehealth Intervention for Ostomy Self-Management NCT06528990 | City of Hope Medical Center | Phase 2 |
| Recruiting | A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors NCT06783569 | JiaRay Group | Phase 1 |
| Recruiting | Efficacy and Safety of Colorectal Anastomotic Leak Testing NCT06865638 | Nanchong Central Hospital | N/A |
| Active Not Recruiting | Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Chinese Participants With Solid Tumors NCT06806046 | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | Phase 1 |
| Completed | Risk Factor Assessment for the Development of Surgical Site Infection in Patients Undergoing Colorectal Cancer NCT07104903 | Oncology Institute of Vojvodina | — |
| Recruiting | Anastomotic Bleeding in Colorectal Anastomosis Relating to the Placement of the Stapler Spike to the Staple Li NCT07506005 | Kepler University Hospital | — |
| Recruiting | The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Underg NCT06565052 | Dana-Farber Cancer Institute | N/A |
| Recruiting | Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid Tumors NCT06621563 | Hansoh BioMedical R&D Company | Phase 1 |
| Recruiting | A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients NCT06497985 | Chipscreen Biosciences, Ltd. | Phase 3 |
| Recruiting | Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment NCT06617858 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Artificial Intelligence-based Screening Models for Prevention and Early Detection of Colorectal Cancer NCT06799793 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | N/A |
| Recruiting | Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial NCT06580002 | University of California, Irvine | Phase 2 |
| Recruiting | Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in C NCT06358430 | M.D. Anderson Cancer Center | Phase 1 |
| Recruiting | SMARTER: Using Blood Samples to iMprove FIT-bAsed coloRecTal cancEr scReening NCT06714318 | Vejle Hospital | — |
| Enrolling By Invitation | Comparing Immediate Removal and Postoperative 1 Day of Urinary Catheter After Colorectal Cancer Surgery NCT06769087 | Seoul St. Mary's Hospital | N/A |
| Completed | Optimizing Postoperative Nutrition in Colorectal Surgery NCT06737211 | National and Kapodistrian University of Athens | N/A |
| Unknown | Introducing a Plant-Based Diet for Patients With Colorectal Diseases NCT05526846 | Stanford University | N/A |
| Not Yet Recruiting | Clinical Outcomes After EMR or ESD of Colorectal Neoplasms - A Multicenter Registry NCT05653960 | Chinese University of Hong Kong | — |
| Recruiting | Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer NCT04516681 | Fudan University | Phase 3 |
| Enrolling By Invitation | Implementation of the ERAS in Colorectal Cancer Patients: a Single Arm Study NCT06729736 | Seoul National University Hospital | N/A |
| Not Yet Recruiting | A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in t NCT06724263 | Tasly Biopharmaceuticals Co., Ltd. | Phase 2 |
| Not Yet Recruiting | BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies NCT06645301 | BioSyngen Pte Ltd | EARLY_Phase 1 |
| Recruiting | Microbiome Testing for the Screening of Colorectal Cancer NCT06588166 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Camera Capsule Endoscopy in the Routine Diagnostic Pathway for Colorectal Diseases NCT06475560 | Odense University Hospital | N/A |
| Active Not Recruiting | Botensilimab and Balstilimab Optimization in Colorectal Cancer NCT06268015 | Nicholas DeVito, MD | Phase 2 |
| Recruiting | FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastati NCT06733038 | Gruppo Oncologico del Nord-Ovest | Phase 3 |
| Recruiting | Different Cycles of Preoperative Neoadjuvant Sintilimab in Mismatch-repair Deficient/microsatellite Instabilit NCT06698757 | Yugui Lian | Phase 2 |
| Completed | Brief Self-Compassion Program in Colorectal Cancer NCT06707337 | Kübra DAKDEVİR | N/A |
| Not Yet Recruiting | EOCRCPred: an AI Model to Predict Survival in EOCRC Patients After Surgery NCT06690606 | Shanghai University of Traditional Chinese Medicine | — |
| Recruiting | Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor NCT07433283 | Sichuan Enray Pharmaceutical Sciences Company | Phase 1 / Phase 2 |
| Terminated | A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer NCT06580938 | Pfizer | Phase 1 |
| Recruiting | Detection of Endoscopic Resection Scars and Delineation of Recurrence is Trainable NCT06193356 | University Hospital, Ghent | N/A |
| Terminated | A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Col NCT06760702 | Aurigene Discovery Technologies Limited | Phase 2 |
| Completed | Study Comparing the Contribution of G-Eye Combined With CAD-Eye Versus High-definition Colonoscopy With CAD-Ey NCT07502469 | Elsan | — |
| Not Yet Recruiting | Blastocystis and Cryptosporidium Infection in Colorectal Cancer Patients NCT06379035 | Assiut University | — |
| Not Yet Recruiting | A PARG Inhibitor DAT-2645 Monotherapy in Patients with Advanced/Metastatic Solid Tumors Harboring BRCA1/2 Loss NCT06614751 | Danatlas Pharmaceuticals Co., Ltd | Phase 1 |
| Recruiting | Triple Assay of Rectal Mucus in the Diagnosis of Colorectal Cancer NCT06649123 | Origin Sciences | — |
| Recruiting | Adjuvant PD-1 Blockade for High-risk Stage-II DMMR/MSI-H Colorectal Cancer NCT06520683 | Sun Yat-sen University | Phase 3 |
| Enrolling By Invitation | Function and Quality of Life After Emergency vs Planned Creation of a Stoma NCT05102981 | Eva Haglind, MD, PhD, professor | — |
| Recruiting | Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors NCT06819215 | Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | Phase 1 / Phase 2 |
| Completed | PeLear CCC: Proyecto Latino Contra Cancer Colorrectal NCT06426927 | University of North Carolina, Chapel Hill | N/A |
| Enrolling By Invitation | Social Media for Colorectal Cancer Screening NCT04296630 | Unity Health Toronto | N/A |
| Recruiting | Total Underwater Colonoscopy (TUC) for Improved Colorectal Cancer Screening: A Randomized Controlled Trial NCT06333392 | Vestre Viken Hospital Trust | N/A |
| Active Not Recruiting | A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors NCT06607185 | Eli Lilly and Company | Phase 1 |
| Recruiting | Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) NCT06077591 | Chinese University of Hong Kong | N/A |
| Recruiting | Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy NCT06090994 | Fudan University | Phase 4 |
| Recruiting | Streamlined Geriatric and Oncological Evaluation Based On IC Technology NCT05720910 | Institut Bergonié | N/A |
| Recruiting | Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers NCT06562192 | Novartis Pharmaceuticals | Phase 1 |
| Recruiting | Colorectal Omics and OfCS Proteoglycans NCT06287671 | Claus Anders Bertelsen, PhD, MD | — |
| Recruiting | Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors NCT06617169 | Monopar Therapeutics | Phase 1 |
| Recruiting | AI-Assisted Non-Contrast CT for Multi-Cancer Screening NCT06632886 | Guo ShiWei | N/A |
| Completed | Enhanced Assistance During Radiotherapy for Unmet Essential Needs NCT06582849 | Washington University School of Medicine | N/A |
| Recruiting | Nurse-led Primary Healthcare Intervention Model in Women's Health Management in Hong Kong NCT06628388 | The University of Hong Kong | N/A |
| Recruiting | ColoReg: A Register for Gastrointestinal Endoscopy Reports and Examination Videos NCT06920680 | Wuerzburg University Hospital | — |
| Active Not Recruiting | Impact of Environmental Factors and Metabolomics on Colorectal Cancer. NCT06643429 | Dong Peng | — |
| Recruiting | Urine Metabolites in the Diagnosis of Disease NCT06710067 | Luventix, Inc. | — |
| Completed | Colorectal Cancer in Young Adults: Study of Incidence, Survival, and Prognostic Factors in Tarragona, Spain NCT07026955 | HJ23 | — |
| Not Yet Recruiting | To Explore the Effect of Huaier Granule on the Negative Conversion Rate After the CEA Level Increases Again Af NCT06665334 | Fudan University | Phase 4 |
| Recruiting | Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Adizutecan (ABBV-400) Moves Th NCT06464692 | AbbVie | Phase 1 / Phase 2 |
| Recruiting | Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer NCT06530303 | Essen Biotech | Phase 1 / Phase 2 |
| Not Yet Recruiting | TP53 R248Q TCR-T Cell Therapy for Advanced Solid Tumor NCT06619886 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | EARLY_Phase 1 |
| Recruiting | A Study to Determine the Effect of CT3001 in Patients with Advanced Solid Tumors NCT06598007 | Crossignal Therapeutics, Inc. | Phase 1 / Phase 2 |
| Recruiting | Precise Oncology Interventions in Nutrition and Training (OnPoint) NCT06534918 | University of Miami | N/A |
| Recruiting | RESPONSE: Colorectal Cancer Survivors' Follow-up Care - Now Digital and Need-based NCT06614647 | University of Aarhus | N/A |
| Recruiting | Predicting Cancer Risk With Digital and Molecular Markers NCT06962670 | University of Erlangen-Nürnberg Medical School | N/A |
| Recruiting | MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors NCT06586515 | Eli Lilly and Company | Phase 1 |
| Active Not Recruiting | Metabolism Imaging-genomics for Predicting the Surgical Outcomes of Colorectal Cancer NCT06614660 | First Affiliated Hospital of Chongqing Medical University | — |
| Active Not Recruiting | Neoadjuvant Therapy for Locally Advanced Rectal Cancer NCT06853769 | The First Affiliated Hospital with Nanjing Medical University | EARLY_Phase 1 |
| Completed | Colorectal Cancer Screening in Xinxiang City NCT06785714 | The First Affiliated Hospital of Xinxiang Medical College | — |
| Recruiting | Telerehabilitation in Cancer Patients: Optimization of Prehabilitation and Rehabilitation Following Colorectal NCT06593678 | Instituto de Investigación Sanitaria Aragón | N/A |
| Recruiting | A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369 | 7 Hills Pharma, LLC | Phase 1 / Phase 2 |
| Recruiting | Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer NCT06557668 | Taichung Veterans General Hospital | — |
| Recruiting | COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascul NCT06185556 | Amsterdam UMC, location VUmc | Phase 2 / Phase 3 |
| Recruiting | Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or NCT06462183 | Rgenta Therapeutics Inc | Phase 1 |
| Recruiting | Multidimensional Examination of Patients with Colorectal and Anal Cancer NCT06562140 | University of Pecs | — |
| Not Yet Recruiting | Robotic Right Hemicolectomy Versus Laparoscopic Right Hemicolectomy NCT06067620 | Jeremy Meyer | N/A |
| Recruiting | Multicentre Study for Data Collection, Development, and Evaluation of Novel CRC Screening and Diagnostic Metho NCT06515821 | Firalis SA | — |
| Completed | Colorectal Cancer Legal and Administrative Burden Support: A Pilot Clinical Trial NCT06475664 | University of Minnesota | EARLY_Phase 1 |
| Recruiting | Community Partnership for Telehealth Solutions to Convey Information and Enhance Care NCT06542835 | University of Arizona | N/A |
| Active Not Recruiting | SafeHeal Anastomosis Feasibility Evaluation (SAFE)-2023 Study NCT06540807 | SafeHeal Inc | N/A |
| Recruiting | Tislelizumab in People With Colorectal Cancer NCT06529523 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Recruiting | Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors NCT06821048 | Weijia Fang, MD | Phase 1 |
| Recruiting | A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointes NCT06500052 | Sichuan Baili Pharmaceutical Co., Ltd. | Phase 1 |
| Active Not Recruiting | Phase II Study of ctDNA-guided Encorafenib Plus Cetuximab Retreatment in Patients BRAF V600E Mutated mCRC NCT06578559 | Gruppo Oncologico del Nord-Ovest | Phase 2 |